−0.355 SEK
−48.11 M SEK
0.00 SEK
243.87 M
About CERENO SCIENTIFIC AB SER. B
Sector
CEO
Sten Randahl Sörensen
Headquarters
Mölndal
Website
Founded
2012
ISIN
SE0008241558
FIGI
BBG00CSMZBJ1
Cereno Scientific AB is a research and development company, which engages in the discovery and development of drug for the preventive treatment of thrombosis related diseases. Its product pipeline include CS1, a reformulation of valproic acid that restores the body's balance between the systems and decreases the risk of blood clot in myocardial infarction or stroke. The company was founded by Claes Sverker Jern, Niklas Olof Bergh, and Pia Larsson in April 2012 and is headquartered in Molndal, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CRNO_B is 5.440 SEK — it has increased by 3.96% in the past 24 hours. Watch CERENO SCIENTIFIC AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CERENO SCIENTIFIC AB SER. B stocks are traded under the ticker CRNO_B.
CRNO_B stock has risen by 8.65% compared to the previous week, the month change is a 11.55% rise, over the last year CERENO SCIENTIFIC AB SER. B has showed a 18.00% increase.
CRNO_B reached its all-time high on Aug 22, 2017 with the price of 11.260 SEK, and its all-time low was 0.445 SEK and was reached on Jun 5, 2023. View more price dynamics on CRNO_B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CRNO_B stock is 8.88% volatile and has beta coefficient of 0.92. Track CERENO SCIENTIFIC AB SER. B stock price on the chart and check out the list of the most volatile stocks — is CERENO SCIENTIFIC AB SER. B there?
Today CERENO SCIENTIFIC AB SER. B has the market capitalization of 1.53 B, it has increased by 0.74% over the last week.
Yes, you can track CERENO SCIENTIFIC AB SER. B financials in yearly and quarterly reports right on TradingView.
CRNO_B net income for the last quarter is −22.72 M SEK, while the quarter before that showed −21.23 M SEK of net income which accounts for −6.99% change. Track more CERENO SCIENTIFIC AB SER. B financial stats to get the full picture.
No, CRNO_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRNO_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CERENO SCIENTIFIC AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CERENO SCIENTIFIC AB SER. B technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CERENO SCIENTIFIC AB SER. B stock shows the buy signal. See more of CERENO SCIENTIFIC AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.